Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Unaudited)

v3.20.4
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (loss)
Total
Balances at Aug. 31, 2019 $ 3,354 $ 10,278,421 $ (4,810,756) $ (9,806) $ 5,461,213
Balances (in shares) at Aug. 31, 2019 3,353,616        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issuance costs   (15,151)     (15,151)
Common shares issued for services - officers   13,000     13,000
Common shares issued for acquisition of license $ 61 539,356     539,417
Common shares issued for acquisition of license (in shares) 61,297        
Common shares issued for settlement of debt $ 11 99,989     100,000
Common shares issued for settlement of debt (in shares) 11,363        
Refund for fractional stock   (117)     (117)
Stock option expense   155,019     155,019
Net loss for the period     (1,306,361)   (1,306,361)
Foreign currency translation adjustments       16,344 16,344
Balances at Nov. 30, 2019 $ 3,426 11,070,517 (6,117,117) 6,538 4,963,364
Balances (in shares) at Nov. 30, 2019 3,426,276        
Balances at Aug. 31, 2020 $ 4,992 13,271,549 (9,465,618) 63,762 $ 3,874,685
Balances (in shares) at Aug. 31, 2020 4,991,587       4,991,587
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common shares issued for cash $ 10,120 6,568,433     $ 6,578,553
Common shares issued for cash (in shares) 10,120,000        
Common shares issued for services - officers   10,500     10,500
Stock option expense   40,868     40,868
Net loss for the period     (1,434,645)   (1,434,645)
Foreign currency translation adjustments       (16,235) (16,235)
Balances at Nov. 30, 2020 $ 15,112 $ 19,891,350 $ (10,900,263) $ 47,527 $ 9,053,726
Balances (in shares) at Nov. 30, 2020 15,111,587       15,111,587